Concepedia
Statistics
Publications
26
Citations
1.9K
H-Index
20
Active since
2000
Affiliations
Karolinska Institutet(Current)
AstraZeneca (Sweden)
Karolinska University Hospital
Uppsala University
AstraZeneca (United States)
Fredrik Erlandsson is an author at Karolinska Institutet specializing in medicine, pharmacology, and oncology.
Publications per year
2000–2021
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E. Rosenberg, Richard Bambury, Eliezer M. Van Allen et al. · Investigational New Drugs · 2013 · 411 citations · Full text
Medicine, Cancer Biology, Oncology +14
Combining intensity, edge and shape information for 2D and 3D segmentation of cell nuclei in tissue sections
Carolina Wählby, Ida‐Maria Sintorn, Fredrik Erlandsson et al. · Journal of Microscopy · 2004 · 357 citations
Computing, Cell Biology, Computer Science +16
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
Silvio Danese, J Rudziński, Wolfgang Brandt et al. · Gut · 2014 · 155 citations
Pharmacy, Immunology, Pharmacotherapy +17
A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
Sarah Maria Rudman, Michael B. Jameson, Mark J. McKeage et al. · Clinical Cancer Research · 2011 · 108 citations · Full text
Medicine, Oncology, Pharmacology +14
Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei
Carolina Wählby, Fredrik Erlandsson, Ewert Bengtsson et al. · Cytometry · 2001 · 89 citations
Medicine, Cell Biology, Pathology +17
1–5 of 26